PubMed دسترسی آزاد

Integrative multi-omics identifies CYP1B1 as a candidate molecular link between toxicant exposure and ferroptosis-related epithelial stress in COPD.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation, chronic airway inflammation, and epithelial remodeling. Although oxidative stress and lipid peroxidation are increasingly recognized as important contributors to COPD pathobiology, the epithelial biomarkers and regulatory pathways linking cigarette-smoke exposure to ferroptosis-related injury remain incompletely defined. OBJECTIVE: This study aimed to identify COPD-associated biomarkers and pathways by integrating bulk transcriptomics, single-cell RNA sequencing, machine-learning analysis, and experimental validation, with a particular focus on the potential association between CYP1B1 and ferroptosis-related epithelial stress. METHODS: Public transcriptomic cohorts, including GSE47460, GSE76925, and GSE37768, were analyzed using differential expression analysis, weighted gene co-expression network analysis, functional enrichment analysis, and machine-learning-based feature prioritization. Single-cell RNA-seq datasets, including GSE196341 and GSE135893, were used to explore cell-type localization of candidate genes. A cigarette-smoke-exposed mouse model and cigarette-smoke extract-treated 16HBE cells were used for experimental validation, and small-scale proteomic data were incorporated as orthogonal supporting evidence. Molecular docking was performed as an exploratory analysis to predict putative interactions between CYP1B1 and candidate compounds. RESULTS: Twenty-four candidate genes were identified by intersecting COPD-associated co-expression modules with differentially expressed genes. Machine-learning analysis prioritized BHLHE22, DPP6, DHRS9, and CYP1B1 as candidate diagnostic biomarkers. The combined model showed high discrimination in the training cohort, with reduced but retained performance in an external validation cohort. Single-gene ROC analysis in an independent dataset suggested moderate discriminatory performance, with CYP1B1 showing relatively consistent performance across analyses. Single-cell analysis indicated that CYP1B1 expression was enriched in airway secretory cell-related populations, and CYP1B1-high airway secretory cells were associated with ferroptosis-related pathway signatures. In cigarette-smoke-exposed mice and CSE-treated 16HBE cells, CYP1B1 expression was increased, accompanied by inflammatory and epithelial injury-related changes. Knockdown of CYP1B1 attenuated CSE-induced alterations in ferroptosis-related markers, including GPX4, MDA, 4-HNE, and GSH/GSSG. Exploratory molecular docking identified several compounds with predicted CYP1B1-binding potential, although experimental validation is required. CONCLUSIONS: Integrative multi-omics and experimental analyses identified CYP1B1 as a candidate COPD-associated epithelial stress biomarker linked to ferroptosis-related signatures in airway secretory cell populations. The findings suggest a potential association between cigarette-smoke-induced CYP1B1 upregulation, lipid peroxidation-related epithelial injury, and epithelial remodeling in COPD. However, CYP1B1 should be considered an exploratory biomarker and putative mechanistic node rather than a validated diagnostic tool or therapeutic target at this stage. Further studies using larger clinically annotated cohorts, smoking-adjusted analyses, cell-type-specific perturbation, ferroptosis rescue experiments, and pharmacological validation are needed.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Biomarker discoveryCOPDCYP1B1Epithelial remodelingFerroptosisMulti-omicsSingle-cell RNA sequencing
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Transcriptional landscape of coding-noncoding RNA interactions in gallstone-associated and de-novo gallbladder carcinoma.

Gallbladder carcinoma (GBC) is an aggressive malignancy characterized by late-stage presentation, poor prognosis, and limited therapeutic options. Gallstones (GS) represent a major risk factor and are implicated in the majority of GBC cases; however, the molecular distinctions between GS-associated GBC (GBCGS) and GS-independent/de novo GBC (dnGBC) remain poorly defined. To date, no GBC subtype-specific molecular biomarkers have been e…

PubMed2026

Integration of network toxicology, machine learning and single-cell sequencing identifies candidate molecular links between air pollutants and hepatocellular carcinoma.

BACKGROUND: Epidemiological studies link long-term air pollution to an increased risk of hepatocellular carcinoma (HCC), but the underlying toxicological targets remain poorly understood. We used an integrative computational framework to identify and prioritize candidate molecular mediators potentially linking pollutant-associated gene signatures with hepatocarcinogenesis. METHODS: We retrieved pollutant-responsive genes associated wit…

PubMed2026

Single-cell transcriptome analysis in ovarian steroid cell tumors-not otherwise specified.

BACKGROUND: Ovarian steroid cell tumors-not otherwise specified (SCT-NOS) is a rare category of sex cord-stromal tumor, however, its pathophysiology is unclear. A comprehensive cellular atlas of ovarian SCT-NOS remains lacking. METHODS: We reported a case of a 41-year-old woman with hyperandrogenism for whom histopathological analysis confirmed the presence of ovarian SCT-NOS. This study utilized single-cell RNA sequencing in a case of…

PubMed2026

FcRn inhibitors in the treatment of CIDP.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated syndrome that causes progressive and relapsing weakness and sensory loss. Evidence-based treatments that have been shown to lessen disability, improve impairment, and prevent relapse include immunoglobulins, corticosteroids, and plasma exchange. While these therapeutics are beneficial to most patients, not all patients respond, residual deficits are …